Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: It's time for clinical trials

Harry W. Flynn, Ingrid U. Scott

Research output: Contribution to journalShort survey

22 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)258-259
Number of pages2
JournalArchives of Ophthalmology
Volume123
Issue number2
DOIs
StatePublished - Feb 1 2005

Fingerprint

Triamcinolone Acetonide
Retinal Vein Occlusion
Vitreous Body
Macular Edema
Diabetic Retinopathy
Glucocorticoids
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

@article{9269502369fd4dd2bac4c1d00d567c1b,
title = "Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: It's time for clinical trials",
author = "Flynn, {Harry W.} and Scott, {Ingrid U.}",
year = "2005",
month = "2",
day = "1",
doi = "10.1001/archopht.123.2.258",
language = "English (US)",
volume = "123",
pages = "258--259",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease

T2 - It's time for clinical trials

AU - Flynn, Harry W.

AU - Scott, Ingrid U.

PY - 2005/2/1

Y1 - 2005/2/1

UR - http://www.scopus.com/inward/record.url?scp=13244256884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13244256884&partnerID=8YFLogxK

U2 - 10.1001/archopht.123.2.258

DO - 10.1001/archopht.123.2.258

M3 - Short survey

C2 - 15710825

AN - SCOPUS:13244256884

VL - 123

SP - 258

EP - 259

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 2

ER -